Ireland has the lowest rate of availability for new cancer medicines in western Europe, according to a new report compiled for the European pharmaceutical body EFPIA.
Only one in four of 56 new cancer treatments licensed since 2020 are available…
Ireland has the lowest rate of availability for new cancer medicines in western Europe, according to a new report compiled for the European pharmaceutical body EFPIA.
Only one in four of 56 new cancer treatments licensed since 2020 are available…